StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) stock

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.04−0.09 (-7.96%)

Close on Nov 18, 2026Market cap $5.02MP/E –Yield –

Alzamend Neuro total assets

Total assets on the balance sheet at the end of each period.

Alzamend Neuro's total assets was $8.54M at Jul 31, 2026. For fiscal 2026 it was $2.08M, down 54.8% from the year before. The highest annual figure on record is $14.52M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2026Apr 30, 2026$2.08M-54.8%
FY2025Apr 30, 2025$4.60M+628.8%
FY2024Apr 30, 2024$631.59K-89.3%
FY2023Apr 30, 2023$5.92M-59.2%
FY2022Apr 30, 2022$14.52M+398.4%
FY2021Apr 30, 2021$2.91M+60.6%
FY2020Apr 30, 2020$1.81M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$8.54M+35.0%
Q4 FY2026CQ1 2026Apr 30, 2026$2.08M-54.8%
Q3 FY2026CQ4 2025Jan 31, 2026$4.04M+142.0%
Q2 FY2026CQ3 2025Oct 31, 2025$5.09M+706.2%
Q1 FY2026CQ2 2025Jul 31, 2025$6.33M+708.4%
Q4 FY2025CQ1 2025Apr 30, 2025$4.60M+368.0%
Q1 FY2025CQ2 2024Jul 31, 2024$1.67M-36.5%
Q4 FY2024CQ1 2024Apr 30, 2024$631.59K-89.3%
Q3 FY2024CQ4 2023Jan 31, 2024$782.64K-90.8%
Q2 FY2024CQ3 2023Oct 31, 2023$983.60K-90.6%
Q1 FY2024CQ2 2023Jul 31, 2023$2.63M-78.5%
Q4 FY2023CQ1 2023Apr 30, 2023$5.92M-59.2%
Q3 FY2023CQ4 2022Jan 31, 2023$8.50M-31.6%
Q2 FY2023CQ3 2022Oct 31, 2022$10.42M-28.1%
Q1 FY2023CQ2 2022Jul 31, 2022$12.21M-27.4%
Q4 FY2022CQ1 2022Apr 30, 2022$14.52M+398.4%
Q3 FY2022CQ4 2021Jan 31, 2022$12.43M+585.2%
Q2 FY2022CQ3 2021Oct 31, 2021$14.50M–
Q1 FY2022CQ2 2021Jul 31, 2021$16.82M–
Q4 FY2021CQ1 2021Apr 30, 2021$2.91M–
Q4 FY2020CQ1 2020Apr 30, 2020$1.81M–

More Alzamend Neuro figures

See a number that looks wrong?